Update 'Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia'

Effect-of-the-dual-5alpha-reductase-inhibitor%2C-dutasteride%2C-on-serum-testosterone-and-body-mass-index-in-men-with-benign-prostatic-hyperplasia.md

@@ -0,0 +1,8 @@
+<br>
+<br>The net androgen effect in any tissue can be viewed as a function of the prevalent intratissue testosterone and DHT concentrations and their relative androgenic potencies (eFigure 6). Furthermore, the relationship of [order testosterone online](https://tea.neuron.my/thorstenhairst) concentrations with these outcomes did not differ between the dutasteride and placebo groups despite substantial differences in DHT concentrations. It is possible that conversion of testosterone to DHT is not obligatory, but that it amplifies the effects of testosterone in tissues with high 5α-reductase activity such as the prostate and skin, but not in tissues with low 5α-reductase activity such as skeletal muscle and bone.
+While SARMs have been examined in preclinical rodent models in the context of their efficacy profiles for managing benign prostate hyperplasia, the effect they have on endogenous anabolic and androgenic activity can be reverse engineered to see its blatant potential in hair loss prevention R. I already know I’m severely prone to hair loss at that dosage with no protection, and I had to test the true extent of Testosterone’s own androgenic activity with DHT totally taken care of to know for sure what was going on in the body and to confirm my suspicions. I used to think they were the devil but I started to research more and realize what the androgenic component of certain anabolics really accomplishes in the body and how it really plays out in the whole cascade of events leading to eventual hair loss progression. In general, the more androgenic a hormone is, the more it will increase prostate size and cause hair loss.
+Changes in prostate volume and PSA level were not significantly related to either testosterone dose or concentration, and did not differ significantly between the placebo and dutasteride groups (eFigure 2). There was no significant interaction between testosterone dose and randomization to dutasteride or placebo, indicating a lack of evidence that the relationship of testosterone dose to change in fat-free mass differed between the dutasteride and placebo groups. Fat-free mass and lean body mass increased in a dose-dependent manner in the placebo and  [www.cives.pl](https://www.cives.pl/johnie27552356) dutasteride groups (FIGURE 2).
+One thing to note, if it wasn’t obvious, there is no scenario in which someone would need to take enough [buy testosterone online without prescription](https://complete-jobs.co.uk/employer/how-to-boost-testosterone-levels-through-healthy-habits) to push their levels up to 2000 ng/dL on Dutasteride (well, at least 99% of the time, the caveat being Free [buy testosterone online without prescription](https://daterondetjolie.fr/@billu584784880) and SHBG issues that may occur). Dutasteride on its own will increase endogenous [buy testosterone online without prescription](http://41.180.4.117:3000/jolieyde831868) levels by up to 26% R. I self-administered a dosage that pushed my Testosterone levels up to about 2000 ng/dL on purpose. I started to give 5-alpha reductase inhibitors more of a chance in my research and experiments. It should be noted that Finasteride and Dutasteride have no effect on muscle growth whatsoever because 5-alpha reductase is only present in muscle tissue in small amounts R. In my videos filmed in the middle of 2018 you can see that I had fairly substantial thinning in the middle of my Dutasteride experiment compared to my hair pre-Dutasteride usage.
+Other studies using finasteride for hirsutism have also found it to be effective. In comparison a full head of hair usually has 120 hair follicles per square centimeter scalp. It may also hide the early symptoms of certain forms of prostate cancer.
+The changes in lean body mass, fat mass, muscle strength, several domains of sexual function, hematocrit level, and levels of total and high-density lipoprotein cholesterol in response to graded doses of testosterone enanthate in men assigned to dutasteride were not significantly different from those assigned to placebo. To determine whether testosterone’s effects on muscle mass, strength, sexual function, hematocrit level, prostate volume, sebum production, and lipid levels are attenuated when its conversion to DHT is blocked by dutasteride (an inhibitor of 5α-reductase type 1 and 2). This argument is supported by the finding that in older men with benign prostatic hyperplasia, the largest reduction in prostate volume with dutasteride is observed in men with low serum testosterone levels.38 However, as circulating testosterone concentrations are increased from physiological to supraphysiological, testosterone alone can maintain prostate volumes even when 5α-reductase activity is suppressed effectively. Thus, the inhibition of testosterone’s conversion to DHT by dutasteride had no significant effect on the ability of testosterone to exert its effects on muscle mass and strength, sexual function, erythropoiesis, plasma lipid levels, prostate volume, and sebum production. Even prostate volume, PSA level, sebum production, and acne scores (markers of androgenic activity in tissues with high 5α-reductase activity) were not affected by dutasteride administration in the range of testosterone concentrations achieved in these men. Because administration of a 5α-reductase inhibitor raises [testosterone store](https://securityholes.science/wiki/Testosterone_Needle_Size_Guide) levels,15–17 which could render the placebo and dutasteride groups unbalanced with respect to testosterone levels, we suppressed endogenous testosterone by administering a long-acting gonadotropin-releasing hormone agonist, and created different levels of circulating testosterone concentrations by administration of graded doses of testosterone enanthate. By inhibiting these two isozymes of 5α-reductase, finasteride reduces the formation of the potent androgen dihydrotestosterone (DHT) from its precursor testosterone in certain tissues in the body such as the prostate gland, skin, and hair follicles.
+<br>